Abstract:Introduction: Adult human cardiomyocytes (CMs) have poor capacity for proliferation and functional recovery after heart attack, thus leading to the high morbidity and mortality of cardiovascular diseases. Thus, there is great need to understand the underlying mechanisms of adult CM turnover and maturation. While screening for modulators of TEAD1, the downstream transcriptional effector of Hippo pathway, my lab identified a novel factor—C5ORF51/RIMOC1—as a potential cardiomyogenic modulator. C5ORF51 (hereinafter referred to as C5x) is a previously uncharacterized protein of nearly unknown function, which appears to play critical roles in the regulation of CM homeostasis and heart size. Hypothesis: C5x is a novel cardiomyogenic regulator which determines CM turnover, maturation, and function. Methods and Results: (1) Ex vivo C5x deletion in mouse neonatal CMs leads to significantly increased percentages of cells in S-G2-M phases, suggesting that C5x mediates CM cell cycle arrest in a cell-autonomous manner; (2) In vivo CM-specific C5x-knockout mouse model shows significantly enhanced CM proliferation in adult mice as well as increased CM endowment and mononuclear diploid populations, indicating that C5x has an essential role in cell replication and division in vivo; (3) With age, C5x-CM-knockout mice develop systolic dysfunction, massive cardiomegaly, late-onset dilated cardiomyopathy, and premature mortality, demonstrating a critical role of C5x in maintaining normal cardiac function; (4) RNA sequencing analysis further reveals that C5x loss-of-function activates fetal gene expression while its gain-of-function suppresses fetal gene expression, suggesting C5x as a gatekeeper of the fetal gene program. Conclusions: C5x is required for CM cell cycle arrest, and its loss results in fetal gene activation leading to a primitive cell state and immature CM expansion.

CHAMP, a Novel Cardiac-Specific Helicase Regulated by MEF2C.

Suppression of Proliferation and Cardiomyocyte Hypertrophy by CHAMP, a Cardiac-Specific RNA Helicase

Suppression of Proliferation I Hypertrophy by CHAMP, a Ca RNA Helicase

Heart tube morphogenesis is regulated by segment-specific gene regulatory networks controlled by MEF2C

The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming

Mir-322/-503 Cluster is Expressed in the Earliest Cardiac Progenitor Cells and Drives Cardiomyocyte Specification

Uncoupling Heart Cell Specification And Migration In The Simple Chordate Ciona Intestinalis

Cbl-Associated Protein CAP contributes to correct formation and robust function of the Drosophila heart tube

Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.

Cooperative Interaction between the Basic Helix-loop-helix Transcription Factor dHAND and Myocyte Enhancer Factor 2C Regulates Myocardial Gene Expression

Myocardin-related transcription factors are required for cardiac development and function

Abstract 1057: MRTF-A and MRTF-B Mediate Redundant Functions Required for Cardiac Development

Myocyte Enhancer Factor 2C and Its Directly-Interacting Proteins: A Review

Fgf Signaling Delineates the Cardiac Progenitor Field in the Simple Chordate, Ciona Intestinalis

Requirements of Myocyte-Specific Enhancer Factor 2a in Zebrafish Cardiac Contractility

Abstract 18695: C5ORF51/RIMOC1 - A Novel Regulator of Cardiogenesis

Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene

Epicardial CCM2 Promotes Cardiac Development and Repair Via its Regulation on Cytoskeletal Reorganization

Nkx2–5 Second Heart Field Target Gene Ccdc117 Regulates DNA Metabolism and Proliferation

Structure of the MADS-box/MEF2 Domain of MEF2A Bound to DNA and Its Implication for Myocardin Recruitment.

CHD4 and SMYD1 repress common transcriptional programs in the developing heart